Hong Kong Stock Market Moves | Kinshore Pharmaceuticals-B (02595.HK) Soared Over 8% in Late Trading, GFH375 Tablets Launched Phase III Clinical Trial for Metastatic Pancreatic Cancer.

According to Zhitong Finance APP, the closing price of Jinfa Pharmaceuticals-B (02595.HK) rose by more than 8%, as of the time of publication, it increased by 7.46% to 31.1 Hong Kong dollars, with a trading volume of 28.0849 million Hong Kong dollars.